ANTHEM BIOSCIENCES
Back to Balance Sheet
|
ANTHEM BIOSCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,606 Cr | ₹2,949 Cr | ₹2,477 Cr | ₹2,105 Cr | ₹1,726 Cr |
What is the latest Total Liabilities ratio of ANTHEM BIOSCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹3,606 Cr |
| Mar2025 | ₹2,949 Cr |
| Mar2024 | ₹2,477 Cr |
| Mar2023 | ₹2,105 Cr |
| Mar2022 | ₹1,726 Cr |
How is Total Liabilities of ANTHEM BIOSCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,606 Cr | 22.29 | |
| Mar2025 | ₹2,949 Cr | 19.05 | |
| Mar2024 | ₹2,477 Cr | 17.68 | |
| Mar2023 | ₹2,105 Cr | 21.94 | |
| Mar2022 | ₹1,726 Cr | - | |
Compare Total Liabilities of peers of ANTHEM BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANTHEM BIOSCIENCES | ₹53,972.0 Cr | 2.6% | 12.2% | 13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,339.0 Cr | -2.7% | -3.7% | 20.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,068.0 Cr | 3.7% | 15.7% | 51% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,767.0 Cr | -0.8% | 1% | 36.2% | Stock Analytics | |
| CIPLA | ₹111,804.0 Cr | -2.1% | -5.2% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,113.4 Cr | -0.8% | -0.5% | -9.3% | Stock Analytics | |
ANTHEM BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANTHEM BIOSCIENCES | 2.6% |
12.2% |
13.5% |
| SENSEX | -1.8% |
-3.7% |
-5.7% |
You may also like the below Video Courses